Venlafaxine-induced gynecomastia in a young patient: A case report

Clinical Neuropharmacology

Volumn 32, Issue 1, 2009, Pages 51-52

  Karakurt, Feridun ^a   Kargili, Ayse ^a   Uz, Burak ^b   Kaya, Arif ^b   Kosar, Ali ^c   Ozkara, Adem ^d   Ozbek, Mehmet ^e  

^a Section of Endocrinology

^b Department of Internal Medicine ^*  (Turkey)

^c Section of Haematology

^d FATIH UNIVERSITY   (Turkey)

^e DISKAPI YILDIRIM BEYAZIT TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Gynecomastia; Imipramine hydrochloride; Prolactin; Venlafaxine

Indexed keywords

ESTRADIOL; IMIPRAMINE; LUTEINIZING HORMONE; PROLACTIN; TESTOSTERONE; VENLAFAXINE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DRUG WITHDRAWAL; ESTRADIOL BLOOD LEVEL; GENERALIZED ANXIETY DISORDER; GYNECOMASTIA; HUMAN; LUTEINIZING HORMONE BLOOD LEVEL; MALE; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; TESTOSTERONE BLOOD LEVEL;

EID: 67749144011     PISSN: 03625664     EISSN: None     Source Type: Journal    
DOI: 10.1097/WNF.0b013e3181679126     Document Type: Article

References (15)

1. TE Andreoli, Carpenter CCJ, Griggs RC, et al. Cecil Essentials of Medicine. Philadelphia: WB Saunders Company; 2001.
2. Carlson HE. Gynecomastia. N Engl J Med 1980;303(14):795-799.
3. Thompson DF, Carter JR. Drug-induced gynecomastia. Pharmacotherapy 1993;(1)13:37-45.
4. Marken PA, Haykal RF, Fisher JN. Management of psychotropic-induced hyperprolactinemia. Clin Pharm 1992; 11(10):851-856.
5. Goeringer K, McIntyre I, Drummer O. Postmortem tissue concentrations of venlafaxine. Forensic Sci Int 2001;121(1-2): 70-75.
6. Wellington K, Perry C. Venlafaxine extended-release: a review of its use in the management of major depression. CNS Drugs 2001;15(8): 643-669.
7. Stah SM. Basic psychopharmacology of antidepressants, part I: antidepressants have seen distinct mechanisms of action. Clin Psychiatry 1998;59(suppl 4):5-14.
8. Mendhekar DN, Andrade CR. Unilateral gynecomastia induced by risperidone in a geriatric male patient. Indian J Med Sci 2005;59(8):361-362.
9. Navarro-Gonzalez M, Alberdi-Leniz A, Gene-Badia J. Gynecomastia by mirtazapin. Med Clin (Barc) 2006;127(1):37-38.
10. Schmutz JL, Barbaud A, Trechot P. Mirtazapin and gynecomastia- galactorrhea. Ann Dermatol Venereol 2005;132(2):195.
11. Lynch A, Madjlessi A. Gynecomastia-galactorrhea during treatment with mirtazapine. Presse Med 2004;33:458.
12. Ma XC, Wang Y, Liu JH, et al. Moclobemide-induced gynecomastia in rats. Acta Pharmacol Sin 2000;21(10):893-896.
13. Sahin M, Yilmaz H, Guvener ND. A possible case of gynecomastia with fluoxetine. Ann Pharmacother 2005;39(3-7):1369.
14. Boulenger A, Viseux V, Plantin-Eon I, et al. Gynecomastia following treatment by fluoxetine. J Eur Acad Dermatol Venereol 2003;17(1):109.
15. Benazzi F. Gynecomastia with risperidone-fluoxetine combination. Pharmacopsychiatry 1999;32(1):41.